Literature DB >> 18214398

[Model for end-stage liver disease. New basis of allocation for liver transplantations].

G E Jung1, J Encke, J Schmidt, A Rahmel.   

Abstract

In December 2006 the allocation of livers from deceased donors in Germany and several other Eurotransplant countries was reset. The previous allocation system relied on CTP score to assess the need of transplantation, but it also assigned to waiting time a prominent role in prioritization. That system was replaced by the primarily urgency-oriented model of end-stage liver disease (MELD) allocation system. First experience with this classification in the U.S.A. shows that MELD scores are able to identify the urgency of liver transplantation correctly in most types of liver disease. Due to the MELD-based allocation, the growing waiting time and waiting-list mortality could be counteracted. At the same time it became evident however that MELD scores do not reflect mortality on the waiting list or thus the urgency for all types of liver diseases. Therefore the new allocation system introduced in the Eurotransplant countries contains standardized and flexible exceptions for these diseases. In addition the new allocation rules were created as a learning system. Repeated "fine tuning" of the allocation process based on continuous monitoring of daily allocation practice and clinical studies aim at just and effective distribution of the precious and limited supply of donor organs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18214398     DOI: 10.1007/s00104-008-1463-4

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  19 in total

1.  MELD and PELD: application of survival models to liver allocation.

Authors:  R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

Review 2.  Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.

Authors:  E Cholongitas; V Shusang; L Marelli; D Nair; M Thomas; D Patch; A Burns; P Sweny; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2007-10-01       Impact factor: 8.171

3.  Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer.

Authors:  Douglas M Heuman; Anastasios Mihas
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

Review 4.  MELD-based liver allocation: who is underserved?

Authors:  Scott W Biggins; Kiran Bambha
Journal:  Semin Liver Dis       Date:  2006-08       Impact factor: 6.115

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  A survey of liver transplantation from living adult donors in the United States.

Authors:  Robert S Brown; Mark W Russo; Michelle Lai; Mitchell L Shiffman; Michael C Richardson; James E Everhart; Jay H Hoofnagle
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

7.  Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?

Authors:  Mary T Austin; Benjamin K Poulose; Wayne A Ray; Patrick G Arbogast; Irene D Feurer; C Wright Pinson
Journal:  Arch Surg       Date:  2007-11

8.  Results of the first year of the new liver allocation plan.

Authors:  Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

9.  Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory.

Authors:  J F Trotter; J Olson; J Lefkowitz; A D Smith; R Arjal; J Kenison
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

Review 10.  Liver transplantation: an update.

Authors:  R C Verdonk; A P van den Berg; M J H Slooff; R J Porte; E B Haagsma
Journal:  Neth J Med       Date:  2007-11       Impact factor: 1.422

View more
  6 in total

1.  Value of the SOFA score as a predictive model for short-term survival in high-risk liver transplant recipients with a pre-transplant labMELD score ≥ 30.

Authors:  Harald Schrem; Melanie Reichert; Benedikt Reichert; Thomas Becker; Frank Lehner; Moritz Kleine; Hüseyin Bektas; Kai Johanning; Christian P Strassburg; Jürgen Klempnauer
Journal:  Langenbecks Arch Surg       Date:  2011-12-06       Impact factor: 3.445

2.  Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.

Authors:  Guido M Kukuk; Stephanie G Schaefer; Rolf Fimmers; Dariusch R Hadizadeh; Samer Ezziddin; Ulrich Spengler; Hans H Schild; Winfried A Willinek
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

3.  Implications of Hyponatremia in Liver Transplantation.

Authors:  Sertac Cimen; Sanem Guler; Subhashini Ayloo; Michele Molinari
Journal:  J Clin Med       Date:  2014-12-29       Impact factor: 4.241

4.  A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma.

Authors:  Krizia Pocino; Cecilia Napodano; Mariapaola Marino; Riccardo Di Santo; Luca Miele; Nicoletta De Matthaeis; Francesca Gulli; Raffaele Saporito; Gian Ludovico Rapaccini; Gabriele Ciasca; Umberto Basile
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

5.  Experience Since MELD Implementation: How Does the New System Deliver?

Authors:  Markus Quante; Christoph Benckert; Armin Thelen; Sven Jonas
Journal:  Int J Hepatol       Date:  2012-10-02

Review 6.  Blockchain and artificial intelligence technology in e-Health.

Authors:  Priti Tagde; Sandeep Tagde; Tanima Bhattacharya; Pooja Tagde; Hitesh Chopra; Rokeya Akter; Deepak Kaushik; Md Habibur Rahman
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-02       Impact factor: 4.223

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.